Blauvelt, A. .; Conrad, C. .; Costanzo, A. .; van de Kerkhof, P. .; Han, G. .; Langley, R. G. .; Davis, L. .; Hoepken, B. .; Wiegratz, S. .; Puig, L. . Bimekizumab Continuous Maintenance of Eesponse at Every Visit Through Two Years in Patients With Moderate to Severe Plaque Psoriasis: Post-Hoc Results from Five Phase 3/3b Trials. J of Skin 2024, 8, s303.